Drug Shortage Report for APO-RABEPRAZOLE
Report ID | 466 |
Drug Identification Number | 02345587 |
Brand name | APO-RABEPRAZOLE |
Common or Proper name | RABEPRAZOLE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-12-20 |
Estimated end date | 2017-05-19 |
Actual end date | 2017-05-19 |
Shortage status | Resolved |
Updated date | 2017-05-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2017-05-23 | French | Compare |
v15 | 2017-05-23 | English | Compare |
v14 | 2017-05-10 | French | Compare |
v13 | 2017-05-10 | English | Compare |
v12 | 2017-04-17 | French | Compare |
v11 | 2017-04-17 | English | Compare |
v10 | 2017-04-04 | French | Compare |
v9 | 2017-04-04 | English | Compare |
v8 | 2017-03-28 | French | Compare |
v7 | 2017-03-28 | English | Compare |
v6 | 2017-03-28 | French | Compare |
v5 | 2017-03-28 | English | Compare |
v4 | 2017-03-27 | French | Compare |
v3 | 2017-03-27 | English | Compare |
v2 | 2017-03-11 | French | Compare |
v1 | 2017-03-11 | English | Compare |
Showing 1 to 16 of 16